6/10
08:06 am
vrdn
Form DEFA14A Viridian Therapeutics,
Medium
Report
Form DEFA14A Viridian Therapeutics,
5/8
07:52 am
vrdn
Form 10-Q Viridian Therapeutics, For: Mar 31
Medium
Report
Form 10-Q Viridian Therapeutics, For: Mar 31
5/8
07:09 am
vrdn
Form 8-K Viridian Therapeutics, For: May 08
Low
Report
Form 8-K Viridian Therapeutics, For: May 08
4/26
08:35 am
vrdn
Form ARS Viridian Therapeutics, For: Dec 31
Low
Report
Form ARS Viridian Therapeutics, For: Dec 31
4/26
08:33 am
vrdn
Form DEFA14A Viridian Therapeutics,
Low
Report
Form DEFA14A Viridian Therapeutics,
4/26
08:31 am
vrdn
Form DEF 14A Viridian Therapeutics, For: Jun 17
Low
Report
Form DEF 14A Viridian Therapeutics, For: Jun 17
4/16
04:06 pm
vrdn
Form 8-K Viridian Therapeutics, For: Apr 10
Low
Report
Form 8-K Viridian Therapeutics, For: Apr 10
4/1
06:39 pm
vrdn
Form SC 13D/A Viridian Therapeutics, Filed by: Fairmount Funds Management LLC
Medium
Report
Form SC 13D/A Viridian Therapeutics, Filed by: Fairmount Funds Management LLC
4/1
06:33 pm
vrdn
Form 4 Viridian Therapeutics, For: Mar 28 Filed by: Fairmount Funds Management LLC
Medium
Report
Form 4 Viridian Therapeutics, For: Mar 28 Filed by: Fairmount Funds Management LLC